Introduction: Pancreatic Neuroendocrine Tumors (PNET), 80% of which are non-functioning, can be hormonally active.
Aim(s): The valuation of carbohydrate metabolism disorders in patients with PNET and impact of annual somatostatin treatment on carbohydrate metabolism parameters.
Materials and methods: The study included 25 PNET patients (7M/18F), mean age - 63.8 y.o.(±16,8). The groups consisted of eight patients with functioning tumors (F-PNET) (seven insulinomas and one glucagonoma) and 17 patients with NF-PNET. There were 14 patients in stage G1, stage G2-10 and stage G3-1. HbA1C, C-peptide, glucose and insulin concentration levels in OGTT were evaluated in DM-free patients and Chromogranin A with 5-OHIO acid in every patient.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Dr Elżbieta Andrysiak-Mamos
To read results and conclusion, please login ...
Further abstracts you may be interested in